Session 8 / Treatments in 2024 and beyond
Chairmen: Frank Bridoux (Poitiers, France), Ric-Paul Hammink (Amyloidosis Alliance, The Netherlands)
02:15 Initial patient-tailored treatment strategy
Marie-Christiane Vekemans (Brussels, Belgium)
02:35 Relapse treatment strategy
Ashutosh Wechalekar (London, Great Britain)
02:55 Ongoing clinical trials
Ute Hegenbart (Heidelberg, Germany)
03:15 Position of organ transplantations in 2024
Nelson Leung (Rochester, USA)
03:35 Discussion